Clinical Trials Logo

Filter by:
NCT ID: NCT01909531 Enrolling by invitation - Parkinson's Disease Clinical Trials

Deep Brain Stimulation (DBS) Data Base Study

Start date: April 2013
Phase:
Study type: Observational

The primary goal of this study is to evaluate and compare outcomes, trends, and effectiveness of both awake and asleep Deep Brain Stimulation (DBS) surgical treatments, target selection, targeting accuracy and outcomes in patients with Parkinson's disease and Essential tremor.

NCT ID: NCT01983215 Enrolling by invitation - Obesity Clinical Trials

Effects of Prevena Therapy on Obese and or Diabetic Patients With Surgical Groin Sites

Start date: April 2013
Phase: N/A
Study type: Interventional

The purpose of the study is to determine the effects of Prevena therapy on decreasing groin surgical site infections in patients who are obese and /or diabetic having vascular surgery.

NCT ID: NCT02116556 Enrolling by invitation - Alcoholic Hepatitis Clinical Trials

Effects of Rifaximin in Patients With Acute Alcoholic Hepatitis

RIFA-AAH
Start date: April 2013
Phase: Phase 2
Study type: Interventional

Acute alcoholic hepatitis (AAH) is a serious condition and one of the most frequent causes of Acute-on-Chronic Liver Failure. The current standard therapy (corticosteroids) is theme of debate and unsatisfactory in many patients (year mortality: 30%). One of the main causes of death is bacterial infections, which affect 40-50% of patients at 90 days. Intestinal decontamination with rifaximin (a nonabsorbable antibiotic) reduces endotoxemia, improves liver function and reduces the complications of decompensated alcoholic cirrhosis. The Hypothesis/Objective: To assess whether oral decontamination with rifaximin prevents the development of infections associated with AAH and analyze its consequences.

NCT ID: NCT02161094 Enrolling by invitation - Type 2 Diabetes Clinical Trials

Diabetes Incentive Performance Study (DIPS) at Shanghai Jiading District

Start date: April 2013
Phase: N/A
Study type: Interventional

Objectives:Physicians from the Shanghai Jiading community clinic were invited to attend the study seminar. Those physicians who meet the criteria of the study plan were being selected to participate voluntarily. From their patient's record, the physicians will recruit a total of 1300 patients with type 2 diabetes who meet the criteria of the Jiading Study. The study utilizes the social learning theory that motivation and social support are important to make behavioral change. The mechanism of providing incentive for patients and physicians will be established after the permission from the Internal Review Board of the hospital and will be approved by the hospital director. Physicians and their patients were randomly divided into 4 groups: Group 1- Physicians only; Group 2 - Patients only; Group 3 - Both Physicians and Patients, Group 4 - control. Groups 1-3 will receive incentives if they can maintain the ideal level of Hemoglobin A1c (HbA1c) during the 3-years study period. The forth group serves as a control and will not receive any incentive but will be provided diabetes education booklet and group education courses for DM control as usual. Based on the annual evaluation of the level of improvement on HbA1c that is a joint effort of both patients and physicians to achieve the targeted goal of adequate HBA1c level, the value of incentives will be increased accordingly. Our ultimate goal is to evaluate the effectiveness of incentive as an intervention tool to improve the health status of the diabetic patients.

NCT ID: NCT03011918 Enrolling by invitation - Nutrition Disorder Clinical Trials

Malnutrition's Role in Fall Risk

Start date: April 2013
Phase: N/A
Study type: Observational

Falls and falls related injuries are considered one of the most adverse events that a patient can experience. Several assessment instruments to assess and mitigate risks for falls have been developed. However, these instruments have not addressed nutritional risk factors. Weight loss and low hemoglobin levels are key components of Malnutrition. Malnutrition in the hospital setting is a significant concern and may play a role as a fall risk factor. The World Health Organization (WHO) maintains a global anemia database. WHO has identified iron deficiency anemia, based on hemoglobin value alone as the most common, wide-spread nutritional deficiency worldwide. Anemia is present in 30% of the worlds population including industrialized nations. The consensus statement of the Academy of Nutrition and Dietetics / American Society of Parenteral and Enteral Nutrition simply defines adult under-nutrition as a continuum of inadequate intake along with a multitude of other factors. Weight loss occurs at multiple points along this continuum. this multiphase retrospective descriptive analysis hypothesizes that degree of weight loss and degree of Hgb decline may be fall risk factors.

NCT ID: NCT01991756 Enrolling by invitation - Clinical trials for Abdominal Aortic Aneurysms

Safety and Performance of Altura Endograft in Abdominal Aortic Aneurysm (AAA) Endovascular Repair

ELEVATE
Start date: April 2014
Phase: N/A
Study type: Observational

The primary objective of the study is to evaluate the acute safety of deploying and implanting the Altura Endograft in the treatment of AAA in subjects who are candidates for endovascular repair. Secondary objectives are to evaluate the acute and longer-term safety and performance of the Altura Endograft through 5 years.

NCT ID: NCT02067897 Enrolling by invitation - Nails, Ingrown Clinical Trials

Nonrandomized Assessment of Ingrown ToenaiLs Treated by Excision of Skinfold Rather Than Toenail

NAILTEST
Start date: April 2014
Phase: N/A
Study type: Observational

Ingrown toenails occur when the nail grows into the surrounding skin, resulting in pain and infection. The most common procedure to treat this problem is a wedge excision (removal of part of the toenail) and matricectomy (destruction of part of the nailbed with chemicals or surgical instruments). This study will evaluate the effectiveness of an alternative technique called the Vandenbos procedure (where the skin is removed and the toenail is left intact). This procedure is currently being used by some of the pediatric surgeons at our hospital and we want to evaluate our results up to 6 months after surgery. We believe that the true recurrence rate will be greater than 0% but that recovery time and morbidity will be acceptable to most patients.

NCT ID: NCT02113345 Enrolling by invitation - Clinical trials for Mild Cognitive Impairment

The Relationship Between Metamemory and Memory in Old Age

M&Mresearch
Start date: April 2014
Phase: N/A
Study type: Interventional

The purpose of this research is to explore the relationship of metamemory and memory of elders and to evaluate the effectiveness of a metamemory cognitive intervention on elders with mild cognitive impairment and low memory self-efficacy.

NCT ID: NCT02138331 Enrolling by invitation - Clinical trials for Diabetes Mellitus Type 1

Effect of Microvesicles and Exosomes Therapy on β-cell Mass in Type I Diabetes Mellitus (T1DM)

Start date: April 2014
Phase: Phase 2/Phase 3
Study type: Interventional

Type 1 diabetes mellitus is strictly autoimmune mediated disease destructing the islets β-cell of the pancreas. Mesenchymal stem cells and its microvesicles are reported as an anti-inflammatory agents. We hypothesis that intravenous infusion of cell free umbilical cord-blood derived MSC microvesicles may reduce the inflammatory state and hence improve the β-cell mass as well as the glycemic control of the patients of T1DM.

NCT ID: NCT02148562 Enrolling by invitation - Hepatitis B Clinical Trials

Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity

Start date: April 2014
Phase: N/A
Study type: Observational

In this project proposal, the investigators will investigate the genetic alterations of Hepatitis B Virus (HBV) strains circulating in Belgian patients who developed end stage liver disease. Additionally, the investigators will compare and link these data sets with three genetic factors involved in immune system response.